Shipra Gandhi, MD, provides updates on neoadjuvant, adjuvant and metastatic therapies for the treatment of HER2-positive breast cancer, hormone receptor positive breast cancer, and triple negative breast cancer.
Related Presenters
Shipra Gandhi, MD, provides updates on neoadjuvant, adjuvant and metastatic therapies for the treatment of HER2-positive breast cancer, hormone receptor positive breast cancer, and triple negative breast cancer.
Related Presenters